Cannabis compound CBD stops coronavirus in test tube, but can it treat Covid? | The Business Standard
Skip to main content
  • Latest
  • Economy
    • Banking
    • Stocks
    • Industry
    • Analysis
    • Bazaar
    • RMG
    • Corporates
    • Aviation
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • Subscribe
    • Get the Paper
    • Epaper
    • GOVT. Ad
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
The Business Standard

Wednesday
July 23, 2025

Sign In
Subscribe
  • Latest
  • Economy
    • Banking
    • Stocks
    • Industry
    • Analysis
    • Bazaar
    • RMG
    • Corporates
    • Aviation
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • Subscribe
    • Get the Paper
    • Epaper
    • GOVT. Ad
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
WEDNESDAY, JULY 23, 2025
Cannabis compound CBD stops coronavirus in test tube, but can it treat Covid?

World+Biz

Reuters
25 January, 2022, 11:00 pm
Last modified: 25 January, 2022, 11:20 pm

Related News

  • Covid: One dead, eight more infected
  • New Covid-19 variant in town: Are we ready to fight the old enemy in a new guise?
  • Triple threat: Dengue, Covid cases surge as chikungunya reemerges
  • Covid-19: 2 more deaths, 4 new cases reported in 24hrs
  • Special health guidelines issued for HSC exams amid covid-19, dengue surge

Cannabis compound CBD stops coronavirus in test tube, but can it treat Covid?

Reuters
25 January, 2022, 11:00 pm
Last modified: 25 January, 2022, 11:20 pm
Photo: Kimzy Nanney/Unsplash
Photo: Kimzy Nanney/Unsplash

Early research suggesting that a popular non-psychoactive compound derived from marijuana might help prevent or treat COVID-19 warrants further investigation in rigorous clinical trials, researchers say.

Several recent laboratory studies of cannabidiol, or CBD, have shown promising results, attracting media attention.

However, many other potential COVID treatments that showed promise in test tubes, from hydroxychloroquine to various drugs used to treat cancer and other diseases, ultimately failed to show benefit for COVID-19 patients once studied in clinical trials.

The Business Standard Google News Keep updated, follow The Business Standard's Google news channel

Marsha Rosner of the University of Chicago led a team that found CBD appeared to help curb SARS-CoV-2 in infected cells in laboratory experiments. "Our findings do not say this will work in patients. Our findings make a strong case for a clinical trial," she said.

Using small doses of highly purified CBD that approximate what patients receive in an oral drug already approved for severe epilepsy, Rosner and colleagues found that CBD did not keep the coronavirus from infecting cells in test tubes.

Rather, it acted soon after the virus entered the cells, blocking it from making copies of itself in part via effects on the inflammatory protein interferon. They found similar effects in infected mice, according to a report in Science Advances.

When they looked at a group of adults with severe epilepsy, the researchers found those who were taking the approved CBD drug had lower rates of COVID-19. But a backward look at a small number of patients does not yield conclusive information. Only randomized clinical trials can do that, Rosner said.

"I know my message is not something people want to hear," she said.

Small doses of tetrahydrocannabinol (THC) - the marijuana ingredient that causes the high - cannabidiolic acid (CBDA), cannabidivarin (CBDV), cannabichromene (CBC), and cannabigerol (CBG) did not keep the virus out of cells or prevent it from replicating, her team found.

"Not only did THC not work, but combining it with CBD prevented CBD from working," Rosner said.

NO COVID CURES AT CBD DISPENSARY

A separate team reported recently in the Journal of Natural Products that high doses of CBG and CBDA do prevent the coronavirus from breaking into cells.

Richard van Breemen from Oregon State University told Reuters that the doses his team tested were non-toxic to cells. It is not clear yet that similarly high doses would be safe for humans, his team said.

"You want the lowest possible effective dose," Rosner said, because of potential side effects as the drug is filtered through the liver.

The CBD her team tested was more than 98% pure, while purity in commercial products is far lower. "People should not run out and get CBD from their favorite dispensary," she said.

CBD products have become widely available in many forms and have been touted - often without proof from clinical trials - as treatments for pain and other ailments.

Small CBD trials in humans with COVID-19 are underway.

In one completed study, researchers in Brazil randomly assigned 105 patients with mild or moderate COVID-19 to receive CBD or a placebo for 14 days along with standard care. The CBD had no apparent effect, according to an October report in Cannabis and Cannabinoid Research.

In a proof-of-concept study at Sheba Medical Center in Israel, researchers are randomly assigning patients with mild COVID to receive CBD or a placebo.

An early-stage trial at Rabin Medical Center, also in Israel, aims to test the effect of CBD in severely or critically ill patients. However, study leader Dr. Moshe Yeshurun told Reuters that accruing participants has been difficult because the current Omicron-driven coronavirus wave "consists mostly of patients with mild to moderate disease."

Rosner's team is exploring the possibility of a clinical trial that would likely focus on asymptomatic or mild cases of COVID. Meanwhile, she is concerned that media reports overstating the potential of cannabinoids will lead people to self-medicate with CBD, stop using masks and avoid vaccines.

"We would love to be able to say specifically" that a certain dose of cannabinoids is helpful, she said, but at this point, "vaccine-induced antibodies and antibody drugs are much more effective at blocking infection."

Top News

Cannabis / Covid -19

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • The meeting is being held at the chief adviser’s official residence Jamuna. Photo: CA Press Wing
    Signs of conspiracies by defeated forces becoming visible: CA Yunus
  • Economist Dr Debapriya Bhattacharya. File photo: UNB
    Another govt exists within the interim administration: Debapriya
  • News of The Day, 23 JULY 2025
    News of The Day, 23 JULY 2025

MOST VIEWED

  • Screengrab/Video collected from Facebook
    CCTV footage shows how Air Force jet nosedived after technical malfunction
  • Photo: Collected
    Bangladeshi man jailed for life in UK for murdering wife in front of their baby
  • Why Bangladesh's capital market is poised for a bull run
    Why Bangladesh's capital market is poised for a bull run
  • ISPR clarifies crashed plane was battle aircraft, not training jet
    ISPR clarifies crashed plane was battle aircraft, not training jet
  • Photo: Syed Zakir Hossain/TBS
    Secretariat protest: 75 injured in police-protester clash over edu adviser's resignation for delaying HSC rescheduling
  • Exim Bank's former chairman Nazrul Islam Majumder being taken to court on 22 July 2025. Photo: Collected
    Will repay all money if granted bail, won’t run away, ex-Exim Bank chair Nazrul tells court

Related News

  • Covid: One dead, eight more infected
  • New Covid-19 variant in town: Are we ready to fight the old enemy in a new guise?
  • Triple threat: Dengue, Covid cases surge as chikungunya reemerges
  • Covid-19: 2 more deaths, 4 new cases reported in 24hrs
  • Special health guidelines issued for HSC exams amid covid-19, dengue surge

Features

Photo: Mehedi Hasan/TBS

Aggrieved nation left with questions as citizens rally to help at burn institute

1d | Panorama
Photo: TBS

Mourning turns into outrage as Milestone students seek truth and justice

22h | Panorama
Illustration: TBS

Uttara, Jatrabari, Savar and more: The killing fields that ran red with July martyrs’ blood

1d | Panorama
Despite all the adversities, girls from the hill districts are consistently pushing the boundaries to earn repute and make the nation proud. Photos: TBS

Ghagra: Where dreams rise from dust for Bangladesh women's football

3d | Panorama

More Videos from TBS

Milestone students demand accurate information about the deceased to be released

Milestone students demand accurate information about the deceased to be released

10m | TBS Today
News of The Day, 23 JULY 2025

News of The Day, 23 JULY 2025

35m | TBS News of the day
What Are the Parties Saying About the Appointment of Other Constitutional Bodies?

What Are the Parties Saying About the Appointment of Other Constitutional Bodies?

45m | TBS Today
Govt mulls allowing trade unions with 20 workers, industry leaders warn of disorder

Govt mulls allowing trade unions with 20 workers, industry leaders warn of disorder

1h | TBS Insight
EMAIL US
contact@tbsnews.net
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Advertisement
  • Privacy Policy
  • Comment Policy
Copyright © 2025
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net